Arvinas Inc and Pfizer Inc Announce ARV-471 Collaboration- Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Arvinas-Pfizer Collaboration Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to hand the conference over to your host today, Randy Teel, Vice President, Corporate Development at Arvinas. Please go ahead.
Thank you, operator. Good morning, everyone, and thank you for joining us to discuss our strategic collaboration with Pfizer, focused on our ER-targeting protectorate, ARV-471. Earlier today, we issued a press release announcing the collaboration. That press release as well as the presentation for today's call can be accessed in the Investors section of Arvinas website and also on the Pfizer website.
With me today are Arvinas President and Chief Executive Officer, John Houston; Chief Financial Officer, Sean Cassidy; and Chief Medical Officer, Ron Peck. In addition, we're pleased to have our Pfizer colleagues: Andy Schmeltz,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |